| Dr Jason Streff, DO | |
|
1 Genesys Pkwy, Grand Blanc, MI 48439-8065 | |
| (810) 606-5985 | |
| Not Available |
| Full Name | Dr Jason Streff |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 1 Genesys Pkwy, Grand Blanc, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477043297 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5101023897 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesys Regional Medical Center - Health Park | Grand blanc, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fenton Family Medicine Pc | 7618006677 | 6 |
News Archive
Children with amblyopia, commonly known as "lazy eye," may have impaired ocular motor function. This can result in difficulties in activities for which sequential eye movements are important, such as reading.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009.
The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., "ignited momentum to shift from 'fighting AIDS' to 'ending AIDS,'" Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has received orphan drug designation by the U.S. Food and Drug Administration for Rose Bengal, the active ingredient in its novel oncology drug PV-10, for the treatment of hepatocellular carcinoma, the most common form of primary liver cancer.
› Verified 5 days ago
| Entity Name | Fenton Family Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720198039 PECOS PAC ID: 7618006677 Enrollment ID: O20100601000247 |
News Archive
Children with amblyopia, commonly known as "lazy eye," may have impaired ocular motor function. This can result in difficulties in activities for which sequential eye movements are important, such as reading.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009.
The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., "ignited momentum to shift from 'fighting AIDS' to 'ending AIDS,'" Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has received orphan drug designation by the U.S. Food and Drug Administration for Rose Bengal, the active ingredient in its novel oncology drug PV-10, for the treatment of hepatocellular carcinoma, the most common form of primary liver cancer.
› Verified 5 days ago
| Entity Name | Genesys Pho Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275820110 PECOS PAC ID: 7618240409 Enrollment ID: O20180419001744 |
News Archive
Children with amblyopia, commonly known as "lazy eye," may have impaired ocular motor function. This can result in difficulties in activities for which sequential eye movements are important, such as reading.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009.
The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., "ignited momentum to shift from 'fighting AIDS' to 'ending AIDS,'" Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has received orphan drug designation by the U.S. Food and Drug Administration for Rose Bengal, the active ingredient in its novel oncology drug PV-10, for the treatment of hepatocellular carcinoma, the most common form of primary liver cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Streff, DO 445 N Fenway Dr, Fenton, MI 48430-2666 Ph: (810) 750-6060 | Dr Jason Streff, DO 1 Genesys Pkwy, Grand Blanc, MI 48439-8065 Ph: (810) 606-5985 |
News Archive
Children with amblyopia, commonly known as "lazy eye," may have impaired ocular motor function. This can result in difficulties in activities for which sequential eye movements are important, such as reading.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009.
The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., "ignited momentum to shift from 'fighting AIDS' to 'ending AIDS,'" Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has received orphan drug designation by the U.S. Food and Drug Administration for Rose Bengal, the active ingredient in its novel oncology drug PV-10, for the treatment of hepatocellular carcinoma, the most common form of primary liver cancer.
› Verified 5 days ago
Dr. Antony James Daros, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8275 Holly Rd, Ste 1, Grand Blanc, MI 48439 Phone: 810-603-0990 Fax: 810-603-1678 | |
Edna Bick, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8447 Holly Rd, Ste D, Grand Blanc, MI 48439 Phone: 810-695-9451 Fax: 810-695-9469 | |
Michael Briggs, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-6137 | |
Dr. Karthiyayini Satkunananthan, M.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Dr. Spencer Ryan Copeland, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Dr. Guru Kandasamy, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Adriana Collazo Ortiz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Ascension Genesys, Gme Dept, One Genesys Pkwy, Grand Blanc, MI 48439 Phone: 800-233-2863 |